Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice

被引:299
作者
Iancu, R [1 ]
Mohapel, P [1 ]
Brundin, P [1 ]
Paul, G [1 ]
机构
[1] Lund Univ, Neuronal Survival Unit, Wallenberg Neurosci Ctr, Dept Expt Med Sci, S-22184 Lund, Sweden
关键词
Parkinson disease; mouse model; 6-OHDA; behavioral tests; tyrosine hydroxylase;
D O I
10.1016/j.bbr.2005.02.023
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Parkinson's disease (PD) is one of the most common neurodegenerative disorders. Several toxin-induced animals models simulate the motor deficits occurring in PD. Among them, the unilateral 6-hydroxydopamine (6-OHDA) model is frequently used in rats and has the advantage of presenting side-biased motor impairments. However, the behavioral consequences of a unilateral 6-OHDA-lesion have, so far, not been described in detail in mice. The aim of this study was to characterize mice with unilateral 6-OHDA-lesions placed in the median forebrain bundle using several motor behavioral tests in order to identify the most suitable predictor of nigral cell loss. Mice underwent various drug-induced (amphetamine- and apomorphine-induced rotation) and spontaneous motor tests (cylinder, rotarod, elevated body swing, and stride length test). The amphetamine-induced rotation test, the cylinder and the rotarod test were most sensitive and reliable in detecting loss of tyrosine hydroxylase-immunoreactive cells in the substantia nigra. This study demonstrates that substantial and stable unilateral 6-OHDA-induced lesions can be established in mice, and that these lesions can be functionally assessed using several different side-bias-based behavioral tests. This mouse model offers the opportunity to use transgenic mouse strains and study the interactions between genes of interest and toxins in relation to Parkinson's disease etiology in the future. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 58 条
[1]   Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system [J].
Abeliovich, A ;
Schmitz, Y ;
Fariñas, I ;
Choi-Lundberg, D ;
Ho, WH ;
Castillo, PE ;
Shinsky, N ;
Verdugo, JMG ;
Armanini, M ;
Ryan, A ;
Hynes, M ;
Phillips, H ;
Sulzer, D ;
Rosenthal, A .
NEURON, 2000, 25 (01) :239-252
[2]   Behavioural recovery after unilateral lesion of the dopaminergic mesotelencephalic pathway: Effect of repeated testing [J].
Abrous, DN ;
Rodriguez, JJ ;
Montaron, MF ;
Aurousseau, C ;
Le Moal, M ;
Barneoud, P .
NEUROSCIENCE, 1998, 84 (01) :213-221
[3]   Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment [J].
Archer, T ;
Palomo, T ;
McArthur, R ;
Fredriksson, A .
NEUROTOXICITY RESEARCH, 2003, 5 (1-2) :95-109
[4]  
ASANUMA M, 1995, ARCH INT PHARMACOD T, V329, P221
[5]   PARKINSONIAN-LIKE LOCOMOTOR IMPAIRMENT IN MICE LACKING DOPAMINE D2 RECEPTORS [J].
BAIK, JH ;
PICETTI, R ;
SAIARDI, A ;
THIRIET, G ;
DIERICH, A ;
DEPAULIS, A ;
LEMEUR, M ;
BORRELLI, E .
NATURE, 1995, 377 (6548) :424-428
[6]   Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice [J].
Bensadoun, JC ;
Mirochnitchenko, O ;
Inouye, M ;
Aebischer, P ;
Zurn, AD .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 (10) :3231-3236
[7]   Lentiviral vectors as a gene delivery system in the mouse midbrain:: Cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF [J].
Bensadoun, JC ;
Déglon, N ;
Tseng, JL ;
Ridet, JL ;
Zurn, AD ;
Aebischer, P .
EXPERIMENTAL NEUROLOGY, 2000, 164 (01) :15-24
[8]  
BORLONGAN CV, 1995, J NEUROSCI, V15, P5372
[9]   THE ROTATING 6-HYDROXYDOPAMINE-LESIONED MOUSE AS A MODEL FOR ASSESSING FUNCTIONAL-EFFECTS OF NEURONAL GRAFTING [J].
BRUNDIN, P ;
ISACSON, O ;
GAGE, FH ;
PROCHIANTZ, A ;
BJORKLUND, A .
BRAIN RESEARCH, 1986, 366 (1-2) :346-349
[10]   A measure of striatal function predicts motor stereotypy [J].
Canales, JJ ;
Graybiel, AM .
NATURE NEUROSCIENCE, 2000, 3 (04) :377-383